EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiome‐Derived Tryptophan Metabolites Regulate AhR Signaling to Restore Epithelial Barrier Integrity in Inflammatory Bowel Disease

Mohammad Ali Mahdiabadi, Asma Moghaddam iD, Nafiseh Erfanian iD

MicrobiologyOpen · 2026-10 · 15 (5)

DOI: 10.1002/mbo3.70386 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, online erschienen am 01.09.2026. Verfasst von Mohammad Ali Mahdiabadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Inflammatory Bowel Diseases, Tryptophan, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation and compromised epithelial barrier integrity. Emerging evidence demonstrates that gut microbiota‐derived tryptophan metabolites serve as endogenous ligands for the aryl hydrocarbon receptor (AhR), initiating protective signaling cascades that restore mucosal homeostasis. This review synthesizes current mechanistic insights into how microbial tryptophan catabolites including indole‐3‐aldehyde, indole‐3‐propionic acid, indole‐3‐lactic acid, and indole‐3‐acetic acid activate AhR to enhance epithelial barrier function. However, this protective capacity is specific to activation by physiological, low‐affinity microbial ligands and should not be generalized to AhR signaling irrespective of ligand identity, dose, or duration of exposure. Key bacterial producers include Lactobacillus species ( L. reuteri and L. plantarum ), Clostridium sporogenes , and Allobaculum species. AhR activation by these metabolites triggers multiple downstream pathways, including AMP‐activated protein kinase (AMPK) activation, which promotes autophagy and mitochondrial homeostasis; nuclear factor erythroid 2‐related factor 2 (Nrf2)‐mediated antioxidant responses; nuclear factor‐κB (NF‐κB) inhibition, which reduces pro‐inflammatory cytokine production; and interleukin‐22 (IL‐22) induction, which supports epithelial regeneration. These signaling events converge to upregulate tight junction proteins, preserve mucus layer integrity, and reduce actomyosin‐mediated permeability through decreased myosin light chain phosphorylation. Preclinical studies demonstrate AhR‐dependent barrier restoration, with protective effects abolished by AhR antagonists. Despite these preclinical findings, their therapeutic utility in IBD remains to be established in human interventional studies. Importantly, the protective effects of AhR are highly context‐dependent, as kynurenine pathway ligands and sustained receptor activation may exert immunosuppressive or pro‐tumorigenic effects, highlighting the importance of ligand selectivity in therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Aryl HydrocarbonInflammatory Bowel DiseasesTryptophanSignal TransductionIntestinal MucosaGastrointestinal MicrobiomeHumansIntestinal Barrier FunctionAnimalsIndolesBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

aryl hydrocarbon receptorepithelial barrierindole metabolitesinflammatory bowel diseasemicrobiomepostbioticstight junctionstryptophan metabolism

Substanzen

Receptors, Aryl HydrocarbonTryptophanIndolesAHR protein, humanindole-3-carbaldehydeBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
  • Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  • Department of Anatomy, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

ORCID-Profile: Asma Moghaddam, Nafiseh Erfanian

Zitieren

APA

Mahdiabadi, M. A., Moghaddam, A., & Erfanian, N. (2026). Microbiome‐Derived Tryptophan Metabolites Regulate AhR Signaling to Restore Epithelial Barrier Integrity in Inflammatory Bowel Disease. MicrobiologyOpen, 15(5). https://doi.org/10.1002/mbo3.70386

Vancouver

Mahdiabadi MA, Moghaddam A, Erfanian N. Microbiome‐Derived Tryptophan Metabolites Regulate AhR Signaling to Restore Epithelial Barrier Integrity in Inflammatory Bowel Disease. MicrobiologyOpen. 2026;15(5). doi:10.1002/mbo3.70386

BibTeX
@article{Mahdiabadi2026,
  author = {Mahdiabadi, Mohammad Ali and Moghaddam, Asma and Erfanian, Nafiseh},
  title = {Microbiome‐Derived Tryptophan Metabolites Regulate AhR Signaling to Restore Epithelial Barrier Integrity in Inflammatory Bowel Disease},
  journal = {MicrobiologyOpen},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/mbo3.70386}
}
Kostenlos starten →